[1]
DE CARVALHO, D.S. , DE SOUZA, R.A. , SFORSIN, A.C. , PINTO, V.B. , MARTINS, M.C. and CHAVES, C.E. 2024. Simulation of the economic impact of introducing rivaroxaban in a high-complexity hospital for venous thromboembolism prophylaxis. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 15, 3 (Jul. 2024), e1153. DOI:https://doi.org/10.30968/rbfhss.2024.153.1153.